Tourangeau Greg bought FULC
January 26, 2024 · Form 4 insider transaction
Tourangeau Greg bought 83,820 shares of Fulcrum Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
83,820
Price
$0.00
Total value
N/A
InsiderTourangeau Greg
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 26, 2024
Filing dateJanuary 30, 2024
Shares owned after83,820
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on January 26, 2024 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2024, subject to the reporting person's continued service on each such vesting date.